[1]
K. Dudzińska, “THE DARK SIDE OF GLP-1 ANALOGS: ADVERSE EFFECTS, LIMITATIONS, AND SAFETY CONCERNS”, IJITSS, vol. 3, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5655.